Johann Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johann Meyer has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Andreas Pich
Core Unit Proteomics and Institute of Toxicology, Hannover Medical School, 30625 Hannover, Germany
1 shared publication- Andrew L. Koenig
Center for Cardiovascular Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
1 shared publication Axel Schambach
Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany
1 shared publicationChen-Leng Cai
Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publicationChristopher Baum
Department of Experimental Hematology, Hannover Medical School Hannover, Germany
1 shared publicationDaniel C Wicke
Department of Experimental Hematology, Hannover Medical School, Hannover, Germany
1 shared publication
Latest Publications
- 17 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6599) , 1343-1347
Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase
Effective tissue repair after myocardial infarction entails a vigorous angiogenic response, guided by incompletely defined immune cell–endothelial cell interactions. We identify the monocyte- and macrophage-derived cytokine METRNL (meteorin-like) as a driver of postinfarction angiogenesis and high-affinity ligand for the stem cell factor receptor KIT (KIT receptor tyrosine kinase). METRNL mediated angiogenic effects in cultured human endothelial cells through KIT-dependent signaling pathways. In a mouse model of myocardial infarction, METRNL promoted infarct repair by selectively expanding the KIT-expressing endothelial cell population in the infarct border zone. Metrnl -deficient mice failed to mount this KIT-dependent angiogenic response and developed severe postinfarction heart failure. Our data establish METRNL as a KIT receptor ligand in the context of ischemic tissue repair.
- 17 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6599) , 1343-1347
Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase
Effective tissue repair after myocardial infarction entails a vigorous angiogenic response, guided by incompletely defined immune cell–endothelial cell interactions. We identify the monocyte- and macrophage-derived cytokine METRNL (meteorin-like) as a driver of postinfarction angiogenesis and high-affinity ligand for the stem cell factor receptor KIT (KIT receptor tyrosine kinase). METRNL mediated angiogenic effects in cultured human endothelial cells through KIT-dependent signaling pathways. In a mouse model of myocardial infarction, METRNL promoted infarct repair by selectively expanding the KIT-expressing endothelial cell population in the infarct border zone. Metrnl -deficient mice failed to mount this KIT-dependent angiogenic response and developed severe postinfarction heart failure. Our data establish METRNL as a KIT receptor ligand in the context of ischemic tissue repair.
- Open Access
- 1 February 2010
- Published by Elsevier in Molecular Therapy
- Vol. 18 (2) , 343-352
Gene Therapy of Mpl Deficiency: Challenging Balance Between Leukemia and Pancytopenia
- 1 February 2010
- Published by Elsevier in Molecular Therapy
- Vol. 18 (2) , 343-352
Open AccessGene Therapy of Mpl Deficiency: Challenging Balance Between Leukemia and Pancytopenia